These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34396904)

  • 1. Lacrimal gland botulinum toxin injection for epiphora management.
    Jeffers J; Lucarelli K; Akella S; Setabutr P; Wojno TH; Aakalu V
    Orbit; 2022 Apr; 41(2):150-161. PubMed ID: 34396904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction.
    Girard B; Piaton JM; Keller P; Abadie C; Nguyen TH
    J Fr Ophtalmol; 2017 Oct; 40(8):661-665. PubMed ID: 28847443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of botulinum toxin-A injection in lacrimal gland and conjunctivodacryocystorhinostomy for treatment of epiphora due to proximal lacrimal system obstruction.
    Kaynak P; Karabulut GO; Ozturker C; Fazil K; Arat YO; Perente I; Akar S; Yilmaz OF; Demirok A
    Eye (Lond); 2016 Aug; 30(8):1056-62. PubMed ID: 27197871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum neurotoxin A injection for the treatment of epiphora with patent lacrymal ducts.
    Girard B; Piaton JM; Keller P; Nguyen TH
    J Fr Ophtalmol; 2018 Apr; 41(4):343-349. PubMed ID: 29681465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on use of botulinum toxin for intractable lacrimal drainage disorders.
    Singh S; Ali MJ; Paulsen F
    Int Ophthalmol; 2018 Oct; 38(5):2233-2238. PubMed ID: 28766277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of lacrimal gland botulinum toxin injection for epiphora in lacrimal obstruction and gustatory tearing.
    Wojno TH
    Ophthalmic Plast Reconstr Surg; 2011; 27(2):119-21. PubMed ID: 21224749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injection for the treatment of epiphora in lacrimal outflow obstruction.
    Ziahosseini K; Al-Abbadi Z; Malhotra R
    Eye (Lond); 2015 May; 29(5):656-61. PubMed ID: 25744443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
    Tu AH; Chang EL
    Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin injection into the lacrimal gland for treatment of proximal nasolacrimal duct obstructions in children.
    Eustis HS; Babiuch A
    J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e75-7. PubMed ID: 25427340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated injections of botulinum toxin-A for epiphora in lacrimal drainage disorders: qualitative and quantitative assessment.
    Ahn C; Kang S; Sa HS
    Eye (Lond); 2019 Jun; 33(6):995-999. PubMed ID: 30765885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of lacrimal gland injection of botulinum toxin in functional versus nonfunctional epiphora.
    Singh S; Nair AG; Alam MS; Mukherjee B
    Oman J Ophthalmol; 2019; 12(2):104-107. PubMed ID: 31198296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin-B injection into the lacrimal gland and posterior cricoarytenoid muscle for the treatment of epiphora and abductor spasmodic dysphonia secondary to Parkinson's disease.
    Sachdev A; Costello D; Madge S
    Orbit; 2019 Jun; 38(3):248-251. PubMed ID: 29939826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral herpes simplex keratitis reactivation after lacrimal gland botulinum toxin injection.
    Narang P; Singh S; Mittal V
    Indian J Ophthalmol; 2018 May; 66(5):697-699. PubMed ID: 29676321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter to the editor regarding the article: "Lacrimal gland botulinum toxin injection for epiphora management".
    Anderson C; Swan RT; Hill R
    Orbit; 2023 Aug; 42(4):468-469. PubMed ID: 36124825
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluating the Effectiveness of Lacrimal Gland Botulinum Toxin Using the TEARS Score.
    Hunt SV; Schulz CB; Malhotra R
    Ophthalmic Plast Reconstr Surg; 2024 Mar-Apr 01; 40(2):192-197. PubMed ID: 38427833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transconjunctival versus Transcutaneous Injection of Botulinum Toxin into the Lacrimal Gland to Reduce Lacrimal Production: A Randomized Controlled Trial.
    Lee AG; Lee SH; Jang M; Lee SJ; Shin HJ
    Toxins (Basel); 2021 Jan; 13(2):. PubMed ID: 33494380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topography of the orbital part of the lacrimal gland for treating epiphora using botulinum toxin injection.
    Shin HJ; You JW; Koh KS; Song WC
    Clin Anat; 2022 Oct; 35(7):861-866. PubMed ID: 35384059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of lacrimal gland botulinum toxin injection in functional versus non-functional epiphora.
    Altin Ekin M
    Cutan Ocul Toxicol; 2024 Dec; 43(4):278-286. PubMed ID: 39287173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of botulinum toxin A in the treatment of functional epiphora.
    Whittaker KW; Matthews BN; Fitt AW; Sandramouli S
    Orbit; 2003 Sep; 22(3):193-8. PubMed ID: 12868028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current clinical application of lacrimal gland injection of botulinum toxin type A in inhibiting lacrimal secretion].
    Xu LP; Bai F; Tao H
    Zhonghua Yan Ke Za Zhi; 2022 Sep; 58(9):722-726. PubMed ID: 36069098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.